Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) is a complete three-drug HIV treatment combining an integrase inhibitor with nucleoside analogs for once-daily therapy. This single-tablet regimen treats HIV-1 infection with high efficacy and improved safety profiles. For patients seeking HIV treatment options, working with qualified HIV specialists ensures proper viral load monitoring and comprehensive care management.
